Moderna to Present at Upcoming Investor Conferences in March

Date : 03/04/2019 @ 10:30PM
Source : Business Wire
Stock : Moderna Inc (MRNA)
Quote : 14.415  0.265 (1.87%) @ 2:58PM

Moderna to Present at Upcoming Investor Conferences in March

Moderna (NASDAQ:MRNA)
Historical Stock Chart

1 Year : From Oct 2018 to Oct 2019

Click Here for more Moderna Charts.

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced its participation in the following upcoming investor conferences:

  • Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March 11, 2019 at 2:50 p.m. ET.
  • Barclays Global Healthcare Conference 2019 in Miami on Thursday, March 14, 2019 at 8:30 a.m. ET.
  • Oppenheimer 29th Annual Healthcare Conference in New York on Tuesday, March 19, 2019 at 8:35 a.m. ET.

A live webcast of each presentation will be available under “Events & Presentations” in the Investors section of the Moderna website at https://investors.modernatx.com/. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentations.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. and Merck, Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been ranked in the top ten of Science’s list of top biopharma industry employers for the past four years. To learn more, visit www.modernatx.com.

Moderna Contacts:Investors:Lorence KimChief Financial Officer617-209-5849Lorence.kim@modernatx.comMedia:Jason GlashowHead, Corporate Communications617-674-5648Jason.glashow@modernatx.com

Latest MRNA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.